Neurocognitive Outcomes over the First 3 Months after Chimeric Antigen Receptor T-Cell (CAR T) Therapy: Preliminary Findings from a Longitudinal Study

被引：0
|
作者：
Mayo, Samantha J. [1 ,2 ]
Edelstein, Kim [2 ]
Bernstein, Lori [2 ]
Coley, Tiana [3 ]
Morrison, Stacey [2 ]
Vijenthira, Abi [3 ]
Maganti, Manjula [4 ]
Kuruvilla, John [3 ]
Crump, Michael [3 ]
Bhella, Sita D. [3 ]
Kridel, Robert [3 ]
Kukreti, Vishal [3 ]
Yang, Chloe [3 ]
Alibhai, Shabbir M. H. [2 ]
Chen, Christine [3 ]
Prica, Anca [3 ]
机构：
[1] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada
[2] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Support Care, Toronto, ON, Canada
[3] Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada
[4] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Biostat, Toronto, ON, Canada
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-190650
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] COVID-19 after hematopoietic cell transplantation and chimeric antigen receptor (CAR)-T-cell therapy
    Kampouri, Eleftheria
    Hill, Joshua A.
    Dioverti, Veronica
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25
  • [42] CHIMERIC ANTIGEN RECEPTOR T CELL (CAR-T) THERAPY IN CHILDREN
    Desai, Devarshi
    Aragon, Camila Gonzalez
    Pabon, Camila
    Sendi, Prithvi Raj
    Meyer, Keith
    Totapally, Balagangadhar
    CRITICAL CARE MEDICINE, 2024, 52
  • [43] Longitudinal patient-reported outcomes in patients receiving chimeric antigen receptor T-cell therapy
    Johnson, P. Connor
    Dhawale, Tejaswini
    Newcomb, Richard A.
    Amonoo, Hermioni L.
    Lavoie, Mitchell W.
    Vaughn, Dagny
    Karpinski, Kyle
    El-Jawahri, Areej
    BLOOD ADVANCES, 2023, 7 (14) : 3541 - 3550
  • [44] Financial toxicity among chimeric antigen receptor T-cell therapy (CAR-T) patients
    Crowder, Sylvia
    Hoogland, Aasha
    Quast, Troy
    Turner, Kea
    Irizarry-Arroyo, Nathaly
    Rodriguez, Yvelise
    Logue, Jennifer
    Locke, Frederick
    Jim, Heather
    PSYCHO-ONCOLOGY, 2021, 30 : 37 - 37
  • [45] CAR-T-OPENIA: Chimeric antigen receptor T-cell therapy-associated cytopenias
    Taneja, Alankrita
    Jain, Tania
    EJHAEM, 2022, 3 : 32 - 38
  • [46] Chimeric antigen receptor T-cell therapy for melanoma
    Razavi, Azadehsadat
    Keshavarz-Fathi, Mahsa
    Pawelek, John
    Rezaei, Nima
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (03) : 209 - 223
  • [47] Chimeric antigen receptor T-cell therapy for ALL
    Maude, Shannon L.
    Shpall, Elizabeth J.
    Grupp, Stephan A.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2014, : 559 - 564
  • [48] The Intersection between Chimeric Antigen Receptor T Cell (CAR-T) Therapy and the Kidneys: A Multicenter Study of Outcomes
    Matarneh, Ahmad
    Sardar, Sundus
    Portela, Rafael
    Abdulbasit, Muhammad
    Verma, Navin
    Trivedi, Naman
    Ghahramani, Nasrollah
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [49] Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis
    Reinhardt, Bryanna
    Lee, Patrick
    Sasine, Joshua P. P.
    CELLS, 2023, 12 (04)
  • [50] Chimeric Antigen Receptor T-Cell Therapy for Glioblastoma
    Ma, Kun
    Hu, Ping
    CANCERS, 2023, 15 (23)
12345